The estimated mean difference was 0.31% (95% bootstrap CI 1.46% to 0.91%), indicating substantial variability in glycemic response
Patients with a single, mild episode triggered by a reversible cause (such as a specific medication now discontinued) may represent a different risk category than those with recurrent episodes or established chronic pancreatitis
References Do, D., Lee, T., Peasah, S
licensed and certified healthcare providers
Medication data included semaglutide dosing categorized as low dose (0.25 to 1 mg weekly) and high dose (1.7 to 2.4 mg weekly), and dose and type of systemic HRT (transdermal or oral estrogen and progestogen use)
One Health Mycology Volume 1 (1) Introducing a new journal: One Health Mycology Sybren de Hoog One Health Mycology 1: 3 (2023)